The effect of cyproterone acetate pretreatment on the in vitro metabolism of aniline, hexobarbital and  3 H-digitoxigenin.
D000726:Androgen Antagonists; D000814:Aniline Compounds / Q000378:metabolism*; D000818:Animals; D002297:Cardanolides / Q000378:metabolism*; D003534:Cyproterone / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000032:analysis; D005260:Female; D006591:Hexobarbital / Q000378:metabolism*; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008862:Microsomes, Liver / Q000032:analysis / Q000378:metabolism; D009929:Organ Size; D011245:Pregnadienes / Q000494:pharmacology*; D011506:Proteins / Q000032:analysis; D051381:Rats; D013148:Spironolactone / Q000494:pharmacology; D014316:Tritium
D000726:Androgen Antagonists; D000814:Aniline Compounds; D002297:Cardanolides; D011245:Pregnadienes; D011506:Proteins; D014316:Tritium; D013148:Spironolactone; D003577:Cytochrome P-450 Enzyme System; D006591:Hexobarbital; D003534:Cyproterone